
Arcus buys majority stake in BitterLiebe
Arcus Capital has acquired a majority stake in Germany-based dietary supplements producer BitterLiebe.
The deal came about via Arcus’s relationship with sell-side M&A adviser Montis Corporate Finance, a spokesperson for Arcus told Unquote.
BitterLiebe participated in TV series Die Höhle der Löwen, Germany’s equivalent of Dragon’s Den, in 2019.
Founders Andre Sierek and Jan Stratmann, as well as business angel Judith Williams, will retain a minority stake and will remain involved in the development of the business, Arcus said in a statement.
The GP intends to assist the company with the expansion of its product range, as well as its expansion to new markets beyond Germany.
Acquisition financing has been provided by Deutsche Bank, alongside mezzanine financing from BayBG, the spokesperson said.
Munich-headquartered Arcus Capital invests via its own capital and alongside co-investors on a deal-by-deal basis, generally investing in DACH-based companies with revenues of €10-150m. Its portfolio companies include sustainable child and baby products business Lässig, which it acquired in December 2019.
According to press reports from 2018, the company expected to generate revenues of around €2m in 2019. However, the company's 2019 revenues were greater than this, the spokesperson said, adding that the business is set to report revenues of more than €7m in 2020.
Company
Established in 2018 and based in Mannheim, BitterLiebe produces dietary supplements and flavourings with a bitter taste, with the intention of bringing this taste back into consumers’ diets. The company claims that its bitter supplements can help to reduce cravings for sweets and improve digestion. Its products are sold via its own website, as well as via Amazon, Rossmann and DM in Germany.
People
Arcus Capital – Stefan Eishold (CEO).
BitterLiebe – Andre Sierek, Jan Stratmann (founders, managing directors).
Advisers
Equity – Gütt Olk Feldhaus (legal).
Vendor – Montis Corporate Finance (M&A).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater